The London Life Sciences Prospective Population Study (abbreviated to the “LOLIPOP study” or “LOLIPOP”) is a major UK research study investigating the mechanisms underlying heart disease stroke, diabetes, obesity and other major medical problems. 

The LOLIPOP study has been running since 2002 and comprises detailed health assessments on more than 30,000 people living in West London. These volunteers will be followed for many years – by observing who remains well over the long-term, we can identify new causes for ill-health. In the future this may in turn enable researchers in the UK and elsewhere to develop new ways to preserve good health. 

The LOLIPOP study is based at Ealing Hospital in West London, and at Imperial College London. We work in close collaboration with a number of major UK and overseas institutions, including Oxford, Cambridge, University College and Harvard Universities, deCODE Genetics and the Beijing Genomics Institute. 

LOLIPOP has established itself as a unique scientific resource and has already been responsible for a number of major discoveries. Our unique study design holds the promise for making further scientific advances in years to come. LOLIPOP is thus a study of national and international importance.